LAB NOTES: ANTICANCER GENES
■ Chemotherapy drugs are the main line of assault in the battle against cancer cells. But they can backfire: as many as 10 percent of long-term survivors of brain tumors and lymphomas eventually come down with leukemia as a reIt of their chemotherapy treatments.
Gespeichert in:
| Veröffentlicht in: | Newsweek 1993-02, Vol.121 (7), p.72G |
|---|---|
| 1. Verfasser: | |
| Format: | Magazinearticle |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7 |
| container_start_page | 72G |
| container_title | Newsweek |
| container_volume | 121 |
| creator | Service, Robert |
| description | ■ Chemotherapy drugs are the main line of assault in the battle against cancer cells. But they can backfire: as many as 10 percent of long-term survivors of brain tumors and lymphomas eventually come down with leukemia as a reIt of their chemotherapy treatments. |
| format | Magazinearticle |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1879130700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1879130700</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_18791307003</originalsourceid><addsrcrecordid>eNpjYuA0NDCz1LUwMYhgYeA0MDCy0LU0MzDhYOAqLs4yMDAAyXIycPo4Oin4-Ye4BvMwsKYl5hSn8kJpbgYNN9cQZw_dgqL8wtLU4pL43Mzi5NScnMS81PzS4nhDC3NLQ2MDcwMDYxKUAgCogCjF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>magazinearticle</recordtype><pqid>1879130700</pqid></control><display><type>magazinearticle</type><title>LAB NOTES: ANTICANCER GENES</title><source>Periodicals Index Online</source><source>EBSCOhost Business Source Complete</source><creator>Service, Robert</creator><creatorcontrib>Service, Robert</creatorcontrib><description>■ Chemotherapy drugs are the main line of assault in the battle against cancer cells. But they can backfire: as many as 10 percent of long-term survivors of brain tumors and lymphomas eventually come down with leukemia as a reIt of their chemotherapy treatments.</description><identifier>ISSN: 0028-9604</identifier><identifier>EISSN: 1069-840X</identifier><language>eng</language><publisher>New York: Newsweek Publishing LLC</publisher><ispartof>Newsweek, 1993-02, Vol.121 (7), p.72G</ispartof><rights>IBT Media, Inc</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,27847</link.rule.ids></links><search><creatorcontrib>Service, Robert</creatorcontrib><title>LAB NOTES: ANTICANCER GENES</title><title>Newsweek</title><description>■ Chemotherapy drugs are the main line of assault in the battle against cancer cells. But they can backfire: as many as 10 percent of long-term survivors of brain tumors and lymphomas eventually come down with leukemia as a reIt of their chemotherapy treatments.</description><issn>0028-9604</issn><issn>1069-840X</issn><fulltext>true</fulltext><rsrctype>magazinearticle</rsrctype><creationdate>1993</creationdate><recordtype>magazinearticle</recordtype><sourceid>HYQOX</sourceid><sourceid>K30</sourceid><recordid>eNpjYuA0NDCz1LUwMYhgYeA0MDCy0LU0MzDhYOAqLs4yMDAAyXIycPo4Oin4-Ye4BvMwsKYl5hSn8kJpbgYNN9cQZw_dgqL8wtLU4pL43Mzi5NScnMS81PzS4nhDC3NLQ2MDcwMDYxKUAgCogCjF</recordid><startdate>19930215</startdate><enddate>19930215</enddate><creator>Service, Robert</creator><general>Newsweek Publishing LLC</general><scope>7QS</scope><scope>BQPUB</scope><scope>ELDFC</scope><scope>HYQOX</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope></search><sort><creationdate>19930215</creationdate><title>LAB NOTES</title><author>Service, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_18791307003</frbrgroupid><rsrctype>magazinearticle</rsrctype><prefilter>magazinearticle</prefilter><language>eng</language><creationdate>1993</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Service, Robert</creatorcontrib><collection>Periodicals Index Online Segment 51</collection><collection>The Newsweek Archive</collection><collection>Periodicals Index Online Segment 00</collection><collection>ProQuest Historical Periodicals</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><jtitle>Newsweek</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Service, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LAB NOTES: ANTICANCER GENES</atitle><jtitle>Newsweek</jtitle><date>1993-02-15</date><risdate>1993</risdate><volume>121</volume><issue>7</issue><spage>72G</spage><pages>72G-</pages><issn>0028-9604</issn><eissn>1069-840X</eissn><abstract>■ Chemotherapy drugs are the main line of assault in the battle against cancer cells. But they can backfire: as many as 10 percent of long-term survivors of brain tumors and lymphomas eventually come down with leukemia as a reIt of their chemotherapy treatments.</abstract><cop>New York</cop><pub>Newsweek Publishing LLC</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-9604 |
| ispartof | Newsweek, 1993-02, Vol.121 (7), p.72G |
| issn | 0028-9604 1069-840X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1879130700 |
| source | Periodicals Index Online; EBSCOhost Business Source Complete |
| title | LAB NOTES: ANTICANCER GENES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T13%3A44%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LAB%20NOTES:%20ANTICANCER%20GENES&rft.jtitle=Newsweek&rft.au=Service,%20Robert&rft.date=1993-02-15&rft.volume=121&rft.issue=7&rft.spage=72G&rft.pages=72G-&rft.issn=0028-9604&rft.eissn=1069-840X&rft_id=info:doi/&rft_dat=%3Cproquest%3E1879130700%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1879130700&rft_id=info:pmid/&rfr_iscdi=true |